Abstract
Cyclodextrins are able to interact in biocatalysis reaction. Their effects as solubilizing agents, inhibitor blocking agents and chiral selectors are well documented and they also interact before the enzyme-catalyzed reaction. Indeed, they have lyo-protectant effect for enzyme in organic medium biocatalysis and they participate in the refolding of inactive enzymes to regain their active form.
Keywords: Cyclodextrin, Biocatalysis, Enzyme, Lyo-protectant, Refolding
Current Organic Chemistry
Title: Enzymatic Catalysis in Presence of Cyclodextrins
Volume: 14 Issue: 13
Author(s): V. Bonnet, C. Gervaise, A. Favrelle, C. Sarazin and F. Djedaini-Pilard
Affiliation:
- Universite de Picardie Jules Verne, CNRS UMR 6219, Laboratoire des Glucides, Institut de Chimie de Picardie, 80039 Amiens, France.,France
Keywords: Cyclodextrin, Biocatalysis, Enzyme, Lyo-protectant, Refolding
Abstract: Cyclodextrins are able to interact in biocatalysis reaction. Their effects as solubilizing agents, inhibitor blocking agents and chiral selectors are well documented and they also interact before the enzyme-catalyzed reaction. Indeed, they have lyo-protectant effect for enzyme in organic medium biocatalysis and they participate in the refolding of inactive enzymes to regain their active form.
Export Options
About this article
Cite this article as:
Bonnet V., Gervaise C., Favrelle A., Sarazin C. and Djedaini-Pilard F., Enzymatic Catalysis in Presence of Cyclodextrins, Current Organic Chemistry 2010; 14(13) . https://dx.doi.org/10.2174/138527210791616849
DOI https://dx.doi.org/10.2174/138527210791616849 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Related Journals
Related Books

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Dysiherbaine: A New Generation of Excitatory Amino Acids of Marine Origin
Central Nervous System Agents in Medicinal Chemistry Hormetic Potential of Sulforaphane (SFN) in Switching Cells’ Fate Towards Survival or Death
Mini-Reviews in Medicinal Chemistry Neurodegenerative Disorders Treatment: The MicroRNA Role
Current Gene Therapy Computer Techniques for Drug Development from Thai Traditional Medicine
Current Pharmaceutical Design Proteolytic Cleavage of Notch: “HIT and RUN”
Current Molecular Medicine Pd Catalyzed N1/N4 Arylation of Piperazine for Synthesis of Drugs, Biological and Pharmaceutical Targets: An Overview of Buchwald Hartwig Amination Reaction of Piperazine in Drug Synthesis
Current Organic Synthesis Pharmacogenetic Studies of Psychotropic Drug-Induced Adverse Effects
Current Pharmacogenomics Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis
Current Pharmaceutical Design Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer
Current Alzheimer Research Social Media Use among Adolescents: Benefits and Risks
Adolescent Psychiatry Gender Difference Response of Male and Female Immunodeficiency Rats Treated with Tissue-specific Biomolecules
Current Pharmaceutical Biotechnology Can Probiotics Supplementation Improve Glycemic and Renal Status in Diabetic Nephropathy? A Systematic Review and Meta-Analysis of Clinical Trials
Endocrine, Metabolic & Immune Disorders - Drug Targets Preface [Hot Topic: Cannabinoid Receptors (Guest Editor: Maria L. Lopez-Rodriguez)]
Current Medicinal Chemistry - Central Nervous System Agents Stress Response Regulation in Panic Disorder
Current Pharmaceutical Design A Critical Approach of the Current Treatment of Anxiety Disorders
Current Psychopharmacology IL-3 Control Tau Modifications and Protects Cortical Neurons from Neurodegeneration
Current Alzheimer Research Cytokine-Purine Interactions in Traumatic Stress, Behavioral Depression,and Sickness
CNS & Neurological Disorders - Drug Targets Overview of Experimental and Conventional Pharmacological Approaches in the Treatment of Sleep and Wake Disorders
Current Topics in Medicinal Chemistry Evidence that Pregnancy Specific Glycoproteins Regulate T-Cell Function and Inflammatory Autoimmune Disease During Pregnancy
Current Drug Targets - Inflammation & Allergy Increasing Neurogenesis with Fluoxetine, Simvastatin and Ascorbic Acid Leads to Functional Recovery in Ischemic Stroke
Recent Patents on Drug Delivery & Formulation